IL1B and ablepharon macrostomia syndrome: For example, individuals who develop AMS have been reported to show decreased plasma levels of IL-10 and increased IL-1β, IL-6, and TNF-α compared to non-AMS controls (Liu et al., 2017; Wang et al., 2018).